Penserra Capital Management LLC Outset Medical, Inc. Transaction History

Penserra Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.07 - $10.25 $14,072 - $46,986	4,584 Added 137.41%	7,920 $42,000
Q3 2023 Nov 15, 2023	SELL	$10.52 - $20.68 $9,604 - $18,880	-913 Reduced 21.49%	3,336 $36,000
Q2 2023 Aug 11, 2023	BUY	$17.18 - $23.76 $63,188 - $87,389	3,678 Added 644.13%	4,249 $92,000
Q1 2023 Apr 24, 2023	BUY	$18.25 - $30.26 $2,664 - $4,417	146 Added 34.35%	571 $10,000
Q4 2022 Feb 13, 2023	SELL	$12.36 - $26.41 $1,025 - $2,192	-83 Reduced 16.34%	425 $10,000
Q3 2022 Nov 14, 2022	BUY	$14.67 - $21.7 $440 - $651	30 Added 6.28%	508 $8,000
Q2 2022 Aug 15, 2022	BUY	$13.46 - $48.16 $6,433 - $23,020	478 New	478 $7,000

19.9M

66.8K

60.3K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $54.2M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.